Axogen Operating Income Over Time
| AXGN Stock | USD 35.38 0.08 0.23% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Axogen Performance and Axogen Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Axogen diversify its offerings? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Axogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.235 | Return On Assets | Return On Equity |
Investors evaluate Axogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Axogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Axogen's market price to deviate significantly from intrinsic value.
Understanding that Axogen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axogen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Axogen's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Income Analysis
Compare Axogen Inc and related stocks such as Iradimed, InMode, and Integra LifeSciences Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IRMD | 1.4 M | 1.4 M | 1.4 M | 2.8 M | 3.1 M | 11.5 M | 10.9 M | 1.3 M | 6 M | 8.6 M | (756.1 K) | 9.8 M | 15.6 M | 20 M | 22 M | 26.1 M | 27.5 M |
| INMD | 669 K | 669 K | 669 K | 669 K | 669 K | 669 K | 669 K | 8.9 M | 23.5 M | 59.6 M | 72.8 M | 167.5 M | 197.9 M | 195.7 M | 112.5 M | 85.4 M | 101.7 M |
| IART | (6 M) | 54.9 M | 73.8 M | (3.6 M) | 65.5 M | 79.6 M | 115.3 M | 44.8 M | 111 M | 93.8 M | 151.4 M | 197.2 M | 238.9 M | 111.5 M | 28.4 M | 32.7 M | 31 M |
| TNDM | (24.2 M) | (24.2 M) | (33 M) | (49.4 M) | (75.7 M) | (69 M) | (78.1 M) | (62.9 M) | (44.6 M) | (16.7 M) | (8 M) | 22.7 M | (92.8 M) | (233.2 M) | (99.1 M) | (78.1 M) | (82 M) |
| AHCO | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | (690) | (1.2 M) | 29.4 M | 71.3 M | 225.6 M | 190.4 M | (598.4 M) | 263.7 M | 237.4 M | 249.2 M |
| CTEV | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 368.2 M | (131.8 M) | 386.1 M | (362.7 M) | 162 M | (1.4 B) | (1.3 B) | (1.2 B) |
| OPK | (2.2 M) | (23.2 M) | (37.3 M) | (79.6 M) | (145.8 M) | (98.5 M) | (73.3 M) | (276.4 M) | (171.2 M) | (274.1 M) | 57.7 M | 18.8 M | (226.3 M) | (157 M) | (152.1 M) | (136.9 M) | (130 M) |
| LFMD | (576.4 K) | (576.4 K) | (540 K) | (546.4 K) | (530.9 K) | (262.2 K) | (1.2 M) | (1.1 M) | (2.1 M) | (2.9 M) | (57.8 M) | (54.3 M) | (43.4 M) | (14.5 M) | (16.1 M) | (14.5 M) | (15.3 M) |
| SANA | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (141.2 M) | (286.1 M) | (356.9 M) | (272.6 M) | (293.1 M) | (272.7 M) | (245.5 M) | (257.7 M) |
| TSHA | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (43 M) | (173.3 M) | (126 M) | (72.4 M) | (91.5 M) | (82.3 M) | (86.4 M) |
Axogen Inc and related stocks such as Iradimed, InMode, and Integra LifeSciences Operating Income description
Operating Income is the amount of profit realized from Axogen Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Axogen Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Axogen Inc | AXGN |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 13631 Progress Boulevard, |
| Exchange | NASDAQ Exchange |
USD 35.38
Check out Axogen Performance and Axogen Correlation. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Axogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.